FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2802422217> ?p ?o ?g. }

• W2802422217 endingPage "291" @default.
• W2802422217 startingPage "285" @default.
• W2802422217 abstract "Monoclonal antibodies targeting key checkpoints in immune stimulatory pathways have over the last years become the mainstay of cancer immunotherapy. This article provides a brief review of the application and key impact of pharmacometrics and quantitative clinical pharmacology approaches in the development of these novel biologics.The clinical development and selection of optimal dosing regimens for monoclonal antibodies used in immune-oncology has been facilitated by an extensive application of pharmacometric approaches to characterize the exposure-response relationship for major efficacy and safety endpoints. These analysis techniques were applied for the anti CTLA-4 antibody ipilimumab, as well as the anti PD1/PD-L1 antibodies nivolumab, pembrolizumab, avelumab, atezolizumab and durvalumab. The utilization of quantitative clinical pharmacology, including model-based analyses, did not only support the identification of efficacious doses with acceptable safety limits, but was also able to address complicating challenges such as time- and response-dependent changes in antibody clearance as observed for most compounds.A widespread and systematic application of pharmacometric approaches has provided key aspects in elucidating, interpreting and integrating preclinical, biochemical and clinical data in support of the development of safe and efficacious dosing regimens of monoclonal antibodies used in immuno-oncology, thereby facilitating the clinical use of this promising new class of biologics in cancer patients with unmet medical needs." @default.
• W2802422217 created "2018-05-17" @default.
• W2802422217 creator A5004332822 @default.
• W2802422217 creator A5058057231 @default.
• W2802422217 date "2018-05-03" @default.
• W2802422217 modified "2023-09-24" @default.
• W2802422217 title "Pharmacometric Applications and Challenges in the Development of Therapeutic Antibodies in Immuno-Oncology" @default.
• W2802422217 cites W1532267411 @default.
• W2802422217 cites W1828044309 @default.
• W2802422217 cites W1950972410 @default.
• W2802422217 cites W1982190722 @default.
• W2802422217 cites W1994993231 @default.
• W2802422217 cites W2010121426 @default.
• W2802422217 cites W2067933166 @default.
• W2802422217 cites W2083133947 @default.
• W2802422217 cites W2097995306 @default.
• W2802422217 cites W2099609050 @default.
• W2802422217 cites W2112196468 @default.
• W2802422217 cites W2150048477 @default.
• W2802422217 cites W2173235643 @default.
• W2802422217 cites W2183144139 @default.
• W2802422217 cites W2197567473 @default.
• W2802422217 cites W2209812019 @default.
• W2802422217 cites W2233779237 @default.
• W2802422217 cites W2284926981 @default.
• W2802422217 cites W2296047035 @default.
• W2802422217 cites W2460196807 @default.
• W2802422217 cites W2528124008 @default.
• W2802422217 cites W2549531711 @default.
• W2802422217 cites W2550340326 @default.
• W2802422217 cites W2554268745 @default.
• W2802422217 cites W2564934728 @default.
• W2802422217 cites W2567068937 @default.
• W2802422217 cites W2572174216 @default.
• W2802422217 cites W2578064406 @default.
• W2802422217 cites W2586157991 @default.
• W2802422217 cites W2597811717 @default.
• W2802422217 cites W2603690292 @default.
• W2802422217 cites W2612703804 @default.
• W2802422217 cites W2615652585 @default.
• W2802422217 cites W2620733650 @default.
• W2802422217 cites W2630105953 @default.
• W2802422217 cites W2672184770 @default.
• W2802422217 cites W2685961074 @default.
• W2802422217 cites W2728093281 @default.
• W2802422217 cites W2775344839 @default.
• W2802422217 cites W2890550793 @default.
• W2802422217 cites W2920938153 @default.
• W2802422217 doi "https://doi.org/10.1007/s40495-018-0142-5" @default.
• W2802422217 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6181227" @default.
• W2802422217 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30319936" @default.
• W2802422217 hasPublicationYear "2018" @default.
• W2802422217 type Work @default.
• W2802422217 sameAs 2802422217 @default.
• W2802422217 citedByCount "7" @default.
• W2802422217 countsByYear W28024222172020 @default.
• W2802422217 countsByYear W28024222172021 @default.
• W2802422217 countsByYear W28024222172022 @default.
• W2802422217 crossrefType "journal-article" @default.
• W2802422217 hasAuthorship W2802422217A5004332822 @default.
• W2802422217 hasAuthorship W2802422217A5058057231 @default.
• W2802422217 hasBestOaLocation W28024222172 @default.
• W2802422217 hasConcept C121608353 @default.
• W2802422217 hasConcept C126322002 @default.
• W2802422217 hasConcept C143998085 @default.
• W2802422217 hasConcept C159654299 @default.
• W2802422217 hasConcept C203014093 @default.
• W2802422217 hasConcept C2775949291 @default.
• W2802422217 hasConcept C2777288759 @default.
• W2802422217 hasConcept C2777701055 @default.
• W2802422217 hasConcept C2777742743 @default.
• W2802422217 hasConcept C2780030458 @default.
• W2802422217 hasConcept C2780035454 @default.
• W2802422217 hasConcept C2780057760 @default.
• W2802422217 hasConcept C2780674031 @default.
• W2802422217 hasConcept C2781433595 @default.
• W2802422217 hasConcept C542903549 @default.
• W2802422217 hasConcept C63433958 @default.
• W2802422217 hasConcept C64903051 @default.
• W2802422217 hasConcept C71924100 @default.
• W2802422217 hasConcept C98274493 @default.
• W2802422217 hasConceptScore W2802422217C121608353 @default.
• W2802422217 hasConceptScore W2802422217C126322002 @default.
• W2802422217 hasConceptScore W2802422217C143998085 @default.
• W2802422217 hasConceptScore W2802422217C159654299 @default.
• W2802422217 hasConceptScore W2802422217C203014093 @default.
• W2802422217 hasConceptScore W2802422217C2775949291 @default.
• W2802422217 hasConceptScore W2802422217C2777288759 @default.
• W2802422217 hasConceptScore W2802422217C2777701055 @default.
• W2802422217 hasConceptScore W2802422217C2777742743 @default.
• W2802422217 hasConceptScore W2802422217C2780030458 @default.
• W2802422217 hasConceptScore W2802422217C2780035454 @default.
• W2802422217 hasConceptScore W2802422217C2780057760 @default.
• W2802422217 hasConceptScore W2802422217C2780674031 @default.
• W2802422217 hasConceptScore W2802422217C2781433595 @default.
• W2802422217 hasConceptScore W2802422217C542903549 @default.
• W2802422217 hasConceptScore W2802422217C63433958 @default.
• W2802422217 hasConceptScore W2802422217C64903051 @default.

• next